Xanthelasma, Xanthelasma, 1726-nm laser
Conditions
Interventions
Patients were treated with 1726 nm laser 3 sessions every 4 weeks.
Then they were instructed to follow up at 1, 3, and 6 months after last treatment.
Experimental Device
Sponsors
Faculty of Medicine Siriraj hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Male or female age 18 years old and older 2. Have Xanthelasma on eyelids
Exclusion criteria
Exclusion criteria: 1. Patients who are pregnant, lactating, and postpartum within 1 year 2. Patients with history of Cushing syndrome or Ehlers-Danlos syndrome 3. Patients with other skin diseases, or having infection at the area of face 4. Immunocompromised patients 5. Patients with hypertrophic scar or keloid 6. Patients with photosensitivity disorder 7. Patients with cancers or skin cancers 8. Patients with mental disorders 9. Received laser treatment or botulinum toxin within the last 6 months before participating in the study 10. Received treatment with filler within 12 months 11. Patients using anticoagulants or antiplatelets
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Global Aesthetic Improvement Scale (GAIS) baseline, 1 month after 1st treatment, 1 month after 2nd treatment and 1, 3, and 6 months after 3rd treatment, Physician | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients improvement scale baseline, 1 month after 1st treatment, 1 month after 2nd treatment and 1, 3, and 6 months after 3rd treatment, Quartile scale,Physicians' improvement scale baseline, 1 month after 1st treatment, 1 month after 2nd treatment and 1, 3, and 6 months after 3rd treatment, Quartile scale,Safety baseline, 1 month after 1st treatment, 1 month after 2nd treatment and 1, 3, and 6 months after 3rd treatment, Adverse events | — |
Countries
Thailand
Contacts
Public ContactWoraphong Manuskiatti
Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed